No results for ‘’
Cipla Ltd
₹1376.50
(0.82%)
Wed, 17 Jun 2026, 09:02 am
Health Technology
Pharmaceuticals: Other
24.5KCipla Return on Equity (ROE) History
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 32.67 | 27.38 | 24.36 | 22.15 | 24.61 | 26.06 | 21.37 | 19.74 | 22.22 | 48.51 | 30.33 | 47.38 | 31.04 | 27.95 | 22.07 | 27.37 | 32.68 | 25.96 | 29.30 | 22.10 |
| Price to book ratio | 10.01 | 5.66 | 4.55 | 3.93 | 4.58 | 3.87 | 3.20 | 3.38 | 3.07 | 5.29 | 3.57 | 3.80 | 3.07 | 2.84 | 2.16 | 3.59 | 3.94 | 3.11 | 4.52 | 3.73 |
| Price to sales ratio | 6.87 | 5.32 | 4.26 | 3.44 | 4.97 | 4.20 | 3.56 | 3.76 | 3.15 | 5.23 | 3.07 | 3.35 | 2.92 | 2.64 | 2.03 | 3.45 | 3.79 | 3.20 | 4.70 | 4.24 |
| Price to cash flow ratio | 73.61 | 51.18 | 45.70 | 47.15 | 25.45 | 25.05 | 14.11 | 20.90 | 20.47 | 55.20 | 25.97 | 21.35 | 31.77 | 26.61 | 11.55 | 17.80 | 24.94 | 22.13 | 28.23 | 22.28 |
| Enterprise value | 20274Cr | 18281Cr | 17582Cr | 17889Cr | 26579Cr | 26265Cr | 23410Cr | 29194Cr | 31660Cr | 58223Cr | 45352Cr | 50760Cr | 46137Cr | 44605Cr | 35502Cr | 64327Cr | 78922Cr | 67571Cr | 114000Cr | 106000Cr |
| Enterprise value to EBITDA ratio | 33.72 | 26.41 | 27.67 | 18.56 | 23.52 | 22.97 | 14.74 | 14.22 | 17.15 | 32.93 | 18.14 | 21.21 | 16.92 | 14.94 | 11.80 | 15.30 | 17.14 | 13.31 | 17.85 | 14.93 |
| Debt to equity ratio | 0.24 | 0.04 | 0.15 | 0.22 | 0 | 0.09 | 0 | 0.11 | 0.12 | 0.16 | 0.45 | 0.33 | 0.29 | 0.29 | 0.20 | 0.11 | 0.05 | 0.03 | 0.02 | 0.01 |
| Return on equity % | 34.36 | 25.60 | 20.05 | 19.03 | 21.11 | 15.74 | 16 | 18.55 | 14.56 | 11.33 | 12.19 | 8.37 | 10.54 | 10.45 | 10.05 | 14.11 | 12.85 | 12.66 | 16.45 | 18.21 |
Cipla Ltd Return on Equity
The Cipla Ltd Return on Equity is a key financial metric used by investors to evaluate Cipla Ltd's valuation, profitability, and overall financial performance. Tracking the Cipla Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Cipla Ltd (NSE: CIPLA, BSE: 500087) is currently trading at ₹1376.50, with a market capitalization of ₹112142.91Cr. As a leading company in the Health technology sector and Pharmaceuticals: other industry, monitoring the Cipla Ltd Return on Equity is essential for fundamental analysis.
Cipla Ltd Return on Equity Current Value
The current Cipla Ltd Return on Equity stands at 18.21.
The latest Cipla Ltd Return on Equity has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Cipla Ltd Return on Equity Historical Trend
The Cipla Ltd Return on Equity has shown the following historical trend:
- 2024: 18.21
- 2023: 16.45
- 2022: 12.66
- 2021: 12.85
- 2020: 14.11
The recent rise in Cipla Ltd Return on Equity suggests strengthening valuation trends and improving market sentiment.
What Cipla Ltd Return on Equity Indicates for Investors
The Cipla Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Cipla Ltd Return on Equity Analysis Summary
The Cipla Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Cipla Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Cipla Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.